Emglev Therapeutics – new member
Emglev is a unique synthetic single domain antibodies company dedicated to discover and develop transformative immunotherapies
Read moreEmglev is a unique synthetic single domain antibodies company dedicated to discover and develop transformative immunotherapies
Read moreAMKbiotech is a CRO providing the biomedical actors with a specialized expertise and tailored services in high-plex spatial biology and cytometry for biomarker identification and treatment efficacy validation.
Read moreValerio Therapeutics is a clinical-stage biotechnology company designing and developing novel oncology drugs targeting tumor DNA repair functions.
Read moreInnate Pharma S.A. is a global, clinical-stage oncology-focused biotech company dedicated to improving treatment and clinical outcomes for patients through therapeutic antibodies that harness the immune system to fight cancer.
Read moreCatalent Limoges is dedicated to the development and manufacture of new biological drugs in the clinical phase, using new-generation molecules.
Read moreThis is a unique website which will require a more modern browser to work!
Please upgrade today!